Skip to main content
. 2021 Jun 23;12:600210. doi: 10.3389/fgene.2021.600210

TABLE 1.

46 likely pathogenic variants in RPGR from 62 unrelated families (based on NM_001034853).

Variants Exon Nucleotide Effect Polyphen2 PROVEAN REVEL CADD BDGP HSF No. of probands Initial diagnosis HGMD Novel or Evidence
change HVAR pred score (reported) Known
Missense and In-frame
1 2 c.124T>C p.Cys42Arg D D 0.897 25.7 / / 1 HM NA Novel 2, 3, 4, 5, 6
2 2 c.149T>G p.Val50Gly D D 0.796 23.2 / / 1 RP NA Novel 2, 3, 4, 5, 6
3 4 c.292C>A p.His98Asn D D 0.84 26.6 / / 1 CORD NA Novel 1, 2, 3, 4, 5, 6
4 5 c.431A>G p.Gln144Arg D D 0.507 24.6 / / 1(1) RP DM Known 2, 3, 4, 5, 6
5 6 c.494G>T p.Gly165Val D D 0.982 26.6 / / 1 RP DM Known 1, 2, 3, 4, 5, 6
6 7 c.748T>C p.Cys250Arg D D 0.906 24.5 / / 1 RP DM Known 2, 3, 4, 5, 6, 7
7 8 c.878G>T p.Arg293Met D D 0.295 13.92 / / 1 RP NA Novel 2, 3, 4, 5, 6,
8 8 c.905G>A p.Cys302Tyr D D 0.919 25.2 / / 1 RP DM Known 2, 3, 4, 5, 6,
9 9 c.958G>A p.Gly320Arg D D 0.959 32 / / 1 RP DM Known 2, 3, 4, 5, 6,
10 10 c.1071_1073 delTGG p.Gly358del / / / / / / 1(1) RP DM? Known 1, 2, 4, 5, 6,
Truncation
1 2 c.140_144dup CTGCT p.Ser47Phefs*23 / / / / / / 1(1) RP NA Known 1, 2, 4, 5, 6
2 6 c.473del p.Asp158Glufs*17 / / / / / / 1(1) RP NA Known 2, 4, 5, 6
3 6 c.530dupT p.Ser178Lysfs*2 / / / / / / 1(1) RP DM Known 1, 2, 4, 5, 6
4 10 c.1243_1244del p.Arg415Glyfs*37 / / / / / / 1 RP DM Known 2, 4, 5, 6
5 14 c.1685_1686del p.His562Argfs*20 / / / / / / 1(1) RP DM Known 1, 2, 4, 5, 6
6 ORF15 c.1872_1873del p.Glu624Aspfs*5 / / / / / / 1 RP NA Known 1, 2, 4, 5, 6
7 ORF15 c.2075dupG p.Glu693Argfs*77 / / / / / / 1(1) RP NA Known 2, 4, 5, 6
8 ORF15 c.2190del p.Glu732Argfs*83 / / / / / / 1 RP NA Novel 1, 2, 4, 5, 6
9 ORF15 c.2236_2237del p.Glu746Argfs*23 / / / / / / 6(2) RP NA Known 1, 2, 4, 5, 6
10 ORF15 c.2272del p.Glu758Lysfs*57 / / / / / / 1 RP NA Novel 1, 2, 4, 5, 6
11 ORF15 c.2384del p.Glu795Glyfs*20 / / / / / / 1 RP NA Known 2, 4, 5, 6
12 ORF15 c.2403_2406del p.Glu802Glyfs*12 / / / / / / 1(1) RP NA Known 2, 4, 5, 6
13 ORF15 c.2405_2406del p.Glu802Glyfs*32 / / / / / / 5(4) HM, RP NA Known 1, 2, 4, 5, 6
14 ORF15 c.2420_2435del p.Glu807Glyfs*3 / / / / / / 1(1) RP NA Known 2, 4, 5, 6
15 ORF15 c.2442_2445del p.Gly817Lysfs*2 / / / / / / 2 MD, RP NA Known 2, 4, 5, 6
16 ORF15 c.2476_2477del p.Arg826Glyfs*8 / / / / / / 2(2) HM, RP NA Known 1, 2, 4, 5, 6
17 ORF15 c.3027_3028del p.Glu1010Glyfs*68 / / / / / / 3(1) HM, RP NA Known 1, 2, 4, 5, 6
18 ORF15 c.3092del p.Glu1031Glyfs*58 / / / / / / 1 HM NA Known 1, 2, 4, 5, 6
19 ORF15 c.3096_3097del p.Glu1033Argfs*45 / / / / / / 2 HM NA Known 1, 2, 4, 5, 6
20 ORF15 c.3241del p.Asp1081Metfs*8 / / / / / / 1(1) HM NA Known 1, 2, 4, 5, 6
21 ORF15 c.3317del p.Lys1106Serfs*25 / / / / / / 1 RP NA Known 2, 4, 5, 6
22 ORF15 c.3364del p.Met1122Cysfs*9 / / / / / / 1(1) HM NA Known 1, 2, 4, 5, 6
23 2 c.93G>A p.Trp31* / / / 33 / / 1 RP DM? Known 1, 2, 4, 5, 6
24 2 c.122C>G p.Ser41* / / / 35 / / 1(1) RP DM Known 1, 2, 4, 5, 6
25 3 c.191G>A p.Trp64* / / / 39 / / 1 RP NA Novel 2, 4, 5, 6
26 5 c.352C>T p.Gln118* / / / 33 / / 2(1) RP DM Known 1, 2, 4, 5, 6, 7
27 10 c.1234C>T p.Arg412* / / / 34 / / 2(1) RP DM Known 1, 2, 4, 5, 6
28 11 c.1345C>T p.Arg449* / / / 23.7 / / 1 RP DM Known 1, 2, 4, 5, 6
29 13 c.1561C>T p.Gln521* / / / 35 / / 1 RP NA Known 1, 2, 4, 5, 6
30 ORF15 c.2248G>T p.Glu750* / / / 24.9 / / 1 RP NA Novel 2, 4, 5, 6
31 ORF15 c.2491G>T p.Glu831* / / / 32 / / 1 RP NA Known 2, 4, 5, 6
32 IVS4 c.310 + 1G>A / / / / 33 SD SD 1(1) RP DM Known 2, 4, 5, 6
33 IVS9 c.1060−1G>A / / / / 33 SA SA 1 RP NA Novel 2, 4, 5, 6
34 IVS12 c.1506 + 1G>T / / / / 33 SD SD 1 HM NA Novel 2, 4, 5, 6
35 IVS12 c.1506 + 2T>C / / / / 32 SD SD 1 RP NA Novel 2, 4, 5, 6
36 IVS13 c.1573−2A>G / / / / 28.2 NSC SA 1 RP DM Known 2, 4, 5, 6

CORD, cone-rod dystrophy; DM, disease-causing mutations; HM, high myopia; MD, macular degeneration; NA, not available; NSC, no splicing change; RP, retinitis pigmentosa; SA, splicing acceptor; SD, splicing donor; *, termination codon; /, not applicable. BDGP, Berkeley Drosophila Genome Project; HGMD, the Human Gene Mutation Database; HSF, Human Splicing Finder; ()∮ : Previously reported by our lab. None of the variants were recorded in gnomAD except c.3027_3028delGG. Evidence that variant is likely pathogenic: 1 = segregate with inherited eye diseases in one or more families (males with variants were affected); 2 = variants identified in one or more families with eye disease accompany with RP, CORD, COD, MD, or HM; 3 = at least three of four predicting tools are pathogenic; 4 = MAF ≤ 4.7 × 10–5 or absence in gnomAD database; 5 = other known IRD pathogenic variants were not identified; 6 = variants does not find in controls; 7 = variants are de novel.